Welcome to LookChem.com Sign In|Join Free
  • or
5,7-Dichloro-1H-indole-2-carboxylic acid ethyl ester is a chemical compound with the molecular formula C11H9Cl2NO2. It is an ester derivative of the indole-2-carboxylic acid, featuring two chlorine atoms attached to the 5th and 7th positions of the indole ring. 5,7-DICHLORO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER is known for its role in the synthesis of pharmaceutical drugs and agrochemicals, as well as its biological activity, which has been studied for potential therapeutic applications in various diseases.

4792-70-5

Post Buying Request

4792-70-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4792-70-5 Usage

Uses

Used in Pharmaceutical Synthesis:
5,7-Dichloro-1H-indole-2-carboxylic acid ethyl ester is used as a key intermediate in the synthesis of pharmaceutical drugs. Its unique chemical structure allows for the development of new drug candidates with potential therapeutic effects against various diseases.
Used in Agrochemical Production:
In the agrochemical industry, 5,7-Dichloro-1H-indole-2-carboxylic acid ethyl ester is utilized as a precursor for the production of various agrochemicals. Its chemical properties make it suitable for the creation of compounds that can be used in crop protection and pest control.
Used in Organic Chemistry Research:
5,7-Dichloro-1H-indole-2-carboxylic acid ethyl ester is a commonly used reagent in organic chemistry for the preparation of related compounds. Its versatility in chemical reactions enables researchers to explore new synthetic pathways and develop novel organic compounds with potential applications in various fields.
Used in Disease Treatment Research:
Due to its biological activity, 5,7-Dichloro-1H-indole-2-carboxylic acid ethyl ester has been studied for its potential use in the treatment of various diseases. Its unique structure and properties make it a promising candidate for further research and development in the field of medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 4792-70-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,9 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4792-70:
(6*4)+(5*7)+(4*9)+(3*2)+(2*7)+(1*0)=115
115 % 10 = 5
So 4792-70-5 is a valid CAS Registry Number.
InChI:InChI=1/C11H9Cl2NO2/c1-2-16-11(15)9-4-6-3-7(12)5-8(13)10(6)14-9/h3-5,14H,2H2,1H3

4792-70-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 5,7-dichloro-1H-indole-2-carboxylate

1.2 Other means of identification

Product number -
Other names 5,7-Dichlor-indol-2-carbonsaeure-ethylester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4792-70-5 SDS

4792-70-5Relevant academic research and scientific papers

SPIROCYCLE COMPOUNDS AND METHODS OF MAKING AND USING SAME

-

, (2019/03/17)

Provided herein are compounds and compositions useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.

PYRAZOLE MAGL INHIBITORS

-

, (2018/12/13)

Provided herein are pyrazole compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.

Synthesis and biological activity of functionalized indole-2-carboxylates, triazino- and pyridazino-indoles

El-Gendy, Adel A.,Said, Mohamed M.,Ghareb, Nagat,Mostafa, Yasser M.,El-Ashry, El Sayed H.

experimental part, p. 294 - 300 (2009/04/11)

Condensation of aryl hydrazines with ethyl pyruvate gave the respective hydrazones 4-6; Fischer indolization led to substituted-1H-indole-2-carboxylic acid ethyl esters 7-9. The Mannich reaction of these compounds with formaldehyde and morpholine yielded ethyl 3-(morpholinomethyl)-substituted-1H-indole-2- carboxylates 10-12. The 5,7-dichloro-1H-indole-2-carbohydrazide 13 was cyclized with methyl orthoformate in DMF to give 6,8-dichloro[1,2,4]triazino[4,5-a]indol- 1(2H)-one 14. Vilsmeier-Haack formylation of 7-9 gave ethyl 3-formyl- substituted-1H-indole-2-carboxylates 15-17 whose 2,2′-((5-chloro-2- (ethoxycarbonyl)-1H-indol-3-yl)methylene)bis-(sulfanediyl) diacetic acid 18 was prepared. The reaction of 15 and 16 with substituted anilines by conventional and microwave methods gave ethyl 3-(N-aryliminomethyl)-5-halo-1H-indole-2- carboxylates 19-29. In a cyclocondensation reaction of 19-25 with thiolactic acid or thioglycolic acid substituted indolylthiazolidinones 30-33 were prepared. Reaction of hydrazine hydrate with 15-17 did not give the respective hydrazones but directly led to the cyclized products substituted-3H- pyridazino[4,5-b]indol-4(5H)-ones 34-36, while a reaction with 2,4-dichlorophenylhydrazine yielded the uncyclized hydrazones. The chlorination of 35 and 36 with POCl3 gave pyridazino[ 4,5-b]indoles 39 and 40, respectively; reaction of the latter compounds with morpholine gave 4-(substituted-5H-pyridazino[4,5-b]indol-4-yl)morpholine 41 and 42. Mannich reaction of 34 with formaldehyde and N-ethylpiperazine gave 8-chloro-3-((4- ethylpiperazin-1-yl)methyl)-3H-pyridazino[ 4,5-b]indol-4(5H)-one 43. The microwave assistance of selected reactions has a profound effect on the reaction speed. The structures of the new compounds were confirmed by both analytical and spectral data. Some compounds were subjected to investigations concerning their antimicrobial, tranquilizing, and anticonvulsant activities.

Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: Role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity

La Regina, Giuseppe,Coluccia, Antonio,Piscitelli, Francesco,Bergamini, Alberto,Sinistra, Anna,Cavazza, Antonella,Maga, Giovanni,Samuele, Alberta,Zanoli, Samantha,Novellino, Ettore,Artico, Marino,Silvestri, Romano

, p. 5034 - 5038 (2008/03/14)

Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern at the indole ring were potent inhibitors of HIV-1 WT and the NNRTI-resistant strains Y181C and K103N-Y181C. These compounds were highly effective against t

The first potent and selective non-imidazole human histamine H4 receptor antagonists

Jablonowski, Jill A.,Grice, Cheryl A.,Chai, Wenying,Dvorak, Curt A.,Venable, Jennifer D.,Kwok, Annette K.,Ly, Kiev S.,Wei, Jianmei,Baker, Sherry M.,Desai, Pragnya J.,Jiang, Wen,Wilson, Sandy J.,Thurmond, Robin L.,Karlsson, Lars,Edwards, James P.,Lovenberg, Timothy W.,Carruthers, Nicholas I.

, p. 3957 - 3960 (2007/10/03)

Following the discovery of the human histamine H4 receptor, a high throughput screen of our corporate compound collection identified compound 6 as a potential lead. Investigation of the SAR resulted in the discovery of novel compounds 10e and 10l, which are the first potent and selective histamine H4 receptor antagonists to be described.

Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides

-

, (2008/06/13)

Processes and intermediates for preparing compounds of Formula (I).

Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors

-

, (2008/06/13)

PCT No. PCT/IB95/00442 Sec. 371 Date Dec. 2, 1997 Sec. 102(e) Date Dec. 2, 1997 PCT Filed Jun. 6, 1995 PCT Pub. No. WO96/39384 PCT Pub. Date Dec. 12, 1996Compounds of Formula (1) wherein R6 is carboxy, (C1-C8)alkoxycarbonyl, benzyloxycarbonyl, C(O)NR8R9 or C(O)R12 as glucogen phosphorylase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4792-70-5